Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Rapid Therapeutic Science Labs Inc (RTSL)

Rapid Therapeutic Science Labs Inc (RTSL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RTSL with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3065 +63.16%
on 06/04/21
0.6000 -16.65%
on 06/10/21
+0.1401 (+38.92%)
since 05/14/21
3-Month
0.3065 +63.16%
on 06/04/21
0.6800 -26.46%
on 03/24/21
-0.0024 (-0.48%)
since 03/15/21
52-Week
0.3065 +63.16%
on 06/04/21
2.0000 -75.00%
on 07/10/20
+0.2901 (+138.14%)
since 06/11/20

Most Recent Stories

More News
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits

/PRNewswire/ -- Cannabidiol (CBD) extract is a product that's derived from cannabis. It's a type of cannabinoid, which are the chemicals naturally found in marijuana plants. Even though it comes from marijuana...

RTSL : 0.5001 (-6.52%)
TLRY : 17.98 (-6.16%)
TLRY.TO : 21.96 (-5.55%)
CRON : 8.72 (-1.69%)
CRON.TO : 10.64 (-0.93%)
ZYNE : 5.43 (-4.06%)
IGC : 1.5800 (-1.86%)
Rapid Therapeutic Finalizes Lab Work on Pharmaceutical Formulas

Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced...

RTSL : 0.5001 (-6.52%)
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels

PALM BEACH,  Fla., /PRNewswire/ --  The recent pandemic has, as we all know, negatively affected almost every business and financial markets across the globe… and even the seemingly ever increasing...

RTSL : 0.5001 (-6.52%)
JAZZ : 183.41 (-1.61%)
NTEC : 3.90 (-7.80%)
CARA : 14.18 (-1.25%)
ARNA : 65.60 (-1.77%)
Rapid Therapeutic Prepares to bring Sublingual Spray Products to Market

Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced...

RTSL : 0.5001 (-6.52%)
Rapid Therapeutic Prepares to file Investigational New Drug Application for its CBD Metered Dose Inhaler with FDA

Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced...

RTSL : 0.5001 (-6.52%)
Global Cannabidiol (CBD) Market Size Expected to Reach $55 Billion In 2028

, /PRNewswire/ -- Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such...

RTSL : 0.5001 (-6.52%)
SNDL : 1.0000 (-5.66%)
TLRY : 17.98 (-6.16%)
TLRY.TO : 21.96 (-5.55%)
KSHB : 0.8800 (-6.63%)
GNLN : 3.66 (-8.27%)
WEED.TO : 29.86 (-1.97%)
CGC : 24.52 (-2.47%)
Cannabis Isolates Cross Over to Pharmaceutical-Grade Products Are More Prevalent Than Ever

, /PRNewswire/ -- In the recent years the use of CBD products have grown exponentially. They have become an everyday item in most people' lives. In drug and food stores, you see CBD infused items next...

TLRY : 17.98 (-6.16%)
APHA : 15.38 (-0.45%)
APHA.TO : 16.55 (-5.59%)
RTSL : 0.5001 (-6.52%)
CGC : 24.52 (-2.47%)
WEED.TO : 29.86 (-1.97%)
RIV.TO : 1.70 (+1.19%)
CRON : 8.72 (-1.69%)
CRON.TO : 10.64 (-0.93%)
Rapid Therapeutic Hires Pharmaceutical Industry Authority to Oversee Labs

Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on employing Metered Dose Inhaler (MDI) technology to deliver...

RTSL : 0.5001 (-6.52%)
Global Market for Cannabinoid-Based Pharmaceuticals Expected to Reach $50 Billion by 2029

PALM BEACH,  Fla., /PRNewswire/ -- The medical segment of the cannabis explosion over the last decade, has not always been in the forefront… but its day is coming. The revenues from cannabinoid-based...

RTSL : 0.5001 (-6.52%)
TLRY : 17.98 (-6.16%)
APHA : 15.38 (-0.45%)
APHA.TO : 16.55 (-5.59%)
CRON : 8.72 (-1.69%)
CRON.TO : 10.64 (-0.93%)
KSHB : 0.8800 (-6.63%)
Rapid Therapeutic Selects Clinical Research Center to Start Clinical Trials Using its Proprietary CBD and CBG Formulation

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI)...

RTSL : 0.5001 (-6.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.8574
2nd Resistance Point 0.7087
1st Resistance Point 0.6044
Last Price 0.5001
1st Support Level 0.3514
2nd Support Level 0.2027
3rd Support Level 0.0984

See More

52-Week High 2.0000
Fibonacci 61.8% 1.3531
Fibonacci 50% 1.1532
Fibonacci 38.2% 0.9534
Last Price 0.5001
52-Week Low 0.3065

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar